OpenNeedle Ask your own

Question explored with the scientific record

how likely is it that SesZenBio can improve hair density and reduce hair loss among menopausal women

Oct 23, 2026 · 9 sources used · OpenNeedle synthesis
SesZenBio was never named in a single study I can find here. Skip it until someone shows you a human trial of that exact product.

The retrieval has no trial of SesZenBio. Every record is about a different product or a different mechanism: minoxidil and finasteride [4], low-level laser and botulinum combinations [2], platelet-rich plasma [5][6], a marine supplement [7], an herbal hair oil [3], and herbal 5-alpha-reductase inhibitors like rosemary and saw palmetto [8][9]. None of that transfers to SesZenBio just because it is marketed for hair. A brand name is not a mechanism.

What is proven in the closest matching evidence is modest and mostly not from menopause-specific studies. PRP, an injection, was the strongest performer for female pattern hair loss: in one placebo-controlled trial it raised density by about 77 hairs per cm² versus about 18 with placebo [5]. A broader meta-analysis puts activated PRP at roughly 28 hairs per cm² over placebo [6]. Even the best therapies show small effects with wide ranges, and the laser meta-analysis flagged likely publication bias [2].

TherapyWhat it didPopulation
PRP vs placebo+77 vs +18 hairs/cm² [5]Female pattern loss
Activated PRP pooled+28 hairs/cm² [6]Mixed alopecia
Minoxidil+finasteride+9 hairs/cm² vs minoxidil [4]Men only
Marine supplementDensity rose, placebo fell [7]Men only

Menopausal women lose density with age regardless: prevalence climbs to 38% at 70+ [1]. Without a trial in that group, no seller can claim the product reverses it.

My call: I have no data on SesZenBio, so its specific likelihood is not estimable, and a product that skips published human trials does not deserve your money. Confidence: high on the gap; not clear on the product itself.

Keep digging

Sources used 9

  1. Hair density, hair diameter and the prevalence of female pattern hair loss British Journal of Dermatology (2001) Thin

    This study investigates the prevalence of female pattern hair loss and its relationship with hair density and diameter in women, revealing that low hair density is a significant factor in the clinical diagnosis of hair loss, particularly as age increases.

    DOI: 10.1046/j.1365-2133.2001.04018.x
  2. Evaluating the efficacy of low-level laser-based treatments for androgenetic alopecia: A network meta-analysis Dermatologica Sinica (2025) meta-analysis Strong

    Network meta-analysis of 26 RCTs (1638 participants) ranked botulinum toxin + red laser + minoxidil best for hair density (OR 13.55) and red laser + LED + PRP best for hair diameter (OR 8.30); no intervention significantly increased adverse events.

    DOI: 10.4103/ds.ds-d-25-00053
  3. Indulekha Bringha hair oil significantly improves hair density and reduces hair fall from roots in comparison to coconut oil in a randomized, single blinded, placebo-controlled clinical trial International Journal of Research in Dermatology (2025) Thin

    Indulekha Bringha oil significantly increases scalp hair density and reduces hair fall from roots compared with coconut oil and no oil in a randomized, single-blind, controlled trial conducted among Indian adults.

    DOI: 10.18203/issn.2455-4529.intjresdermatol20252065
  4. Comparing minoxidil-finasteride mixed solution with minoxidil solution alone for male androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials Frontiers in Medicine (2025) meta-analysis Strong

    Topical minoxidil-finasteride combination was superior to minoxidil monotherapy for male androgenetic alopecia in pooled RCT evidence, improving hair density, hair diameter, and global photographic assessment, but evidence certainty was low to moderate and confirmatory trials ar…

    DOI: 10.3389/fmed.2025.1632139
  5. The effect of autologous activated platelet‐rich plasma injection on female pattern hair loss: A randomized placebo‐controlled study Journal of Cosmetic Dermatology (2017) Thin

    This randomized placebo-controlled study evaluates the efficacy and safety of autologous platelet-rich plasma (PRP) injections in treating female pattern hair loss, demonstrating significant improvements in hair density and thickness compared to placebo.

    DOI: 10.1111/jocd.12357
  6. Platelet-Rich Plasma in the Management of Alopecia: A Systematic Review and Meta-Analysis of Clinical Evidence Dermatology and Therapy (2025) Thin

    A comprehensive systematic review and meta-analysis evaluating the safety and efficacy of platelet-rich plasma (PRP) for alopecia across subtypes, showing activated PRP increases hair density and is generally safe, with variable effects on hair thickness and mixed results versus…

    DOI: 10.1007/s13555-025-01542-8
  7. A 6‐month, randomized, double‐blind, placebo‐controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair Journal of Cosmetic Dermatology (2016) Thin

    Twice-daily marine complex supplement Viviscal Man significantly increased total hair count, hair density, and terminal hair density and reduced hair shedding over 6 months in men with thinning hair, with no treatment-emergent adverse events reported.

    DOI: 10.1111/jocd.12265
  8. Hair loss and herbs for treatment Journal of Cosmetic Dermatology (2013) Thin

    This article provides a comprehensive literature review of hair loss causes, with a focus on natural herbal therapies, detailing active plant compounds, their proposed mechanisms (notably 5α-reductase inhibition and anti-androgen effects), clinical and preclinical evidence, safe…

    DOI: 10.1111/jocd.12051
  9. Promotion of Hair Growth by Rosmarinus officinalis Leaf Extract Phytotherapy Research (2012) Thin

    Rosmarinus officinalis leaf extract promotes hair growth in androgen-sensitive mouse models and inhibits androgen signaling by blocking testosterone 5α-reductase and DHT–androgen receptor binding, with 12‑methoxycarnosic acid identified as an active constituent.

    DOI: meta/10.1002/ptr.4712

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →